Loading company…
Maculaser develops laser therapy technology for retinal diseases, including macular degeneration and diabetic retinopathy.
Founded in 2020 by Jani Tirronen, Teemu Turunen and Ossi Kaikkonen, Maculaser develops laser therapy for retinal diseases. Its technology uses electroretinography to control retinal temperature during laser treatment. The company is based in Helsinki, Finland, and raised EUR 1.2 million from Innovestor in February 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in